Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model

Human and Experimental Toxicology

Volumn 21, Issue 4, 2002, Pages 197-203

  Dachir, Shlomit ^a   Fishbeine, E ^a   Meshulam, Y ^a   Sahar, R ^a   Amir, A ^a   Kadar, T ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Inflammation; Mouse ear vesicant model; Non steroidal anti inflammatory drugs; Steroids; Sulfur mustard

Indexed keywords

ADEXONE; ALCOHOL; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BENZALKONIUM CHLORIDE; BENZYL ALCOHOL; CAPSAICIN; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DEXAMYCIN; DEXEFRIN; DICLOFENAC; DICLOFENAC DERIVATIVE; HYDROCORTISONE; IBULEVE; IBUPROFEN; INDOMETACIN; MUSTARD GAS; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLEPHRINE; PIROXICAM; POVIDONE IODINE; PROPYLENE GLYCOL; STEROID; ZOSTRIX HP; IRRITANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; EXTERNAL EAR; FOLLOW UP; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SKIN TOXICITY; WAKEFULNESS; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EAR; EDEMA; INJURY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-INFLAMMATORY AGENTS, STEROIDAL; COMPARATIVE STUDY; EAR; EDEMA; IRRITANTS; MICE; MODELS, ANIMAL; MUSTARD GAS; SKIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; STEROIDS;

ANIMALIA;

EID: 0035997884     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327102ht229oa     Document Type: Article

References (32)

1. Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy
2. The sulfur mustard injury: Description of lesions and resulting incapacitation. Medical defense against mustard gas, toxic mechanisms and pharmacological implications
3. Histand cytopathology of acute epithelial lesions. Medical defense against mustard gas, toxic mechanisms and pharmacological implications
4. Toxicity of mustard gas skin lesion
5. Putative roles of inflammation in the dermatopathology of sulfur mustard
6. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin
7. Pathology produced by sulfur mustard in human skin graft on athymic nude mice: I. Gross and light microscopic changes
8. Pathology produced by sulfur mustard in human skin graft on athymic nude mice: II. Ultrastructural changes
9. Characterization of the sulfur mustard vapor induced cutaneous lesions on hairless guinea pigs
10. The haired guinea pig as a vesicant animal model
11. Structural changes induced by sulphur mustard in rabbit skin
12. Toxicokinetics of topical sulfur mustard penetration, disposition, and vascular toxicity in isolated perfused porcine skin
13. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard
14. A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear
15. The mouse ear model of cutaneous sulfur mustard injury
16. Inhibition of arachidonic acid-induced ear oedema as a model for assessing topical anti-inflammatory compounds
17. Mouse ear assays as models for studying mechanisms of chemically induced irritation
18. Molecular basis for mustard-induced vesication
19. Toxicodynamics of sulfur mustard
20. Assessment of sulfur mustard interaction with basement membrane components
21. A novel multiple therapeutic approach (MTA) for suppression of the inflammatory and immunology responses observed in vesicant injury
22. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model
23. Clinical management of mustard gas casualties
24. Toxicology of mustard gas
25. Excitement in vesicant research - Yesterday, today and tomorrows
26. Mustard gas: Clinical, toxicological, and mutagenic aspects based on modern experience
27. Therapeutic approaches to dermatotoxicity by sulfur mustard: I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model
28. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM)
29. Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin
30. Iodine protects against sulfur mustard-induced skin lesions
31. Effect of topically applied drugs against HD-induced cutaneous injury in the mouse ear edema model
32. Assessment of epidermal-dermal junction epitopes in the HD-exposed mouse ear vesicant model